Quantamental Technologies’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Quantamental Technologies's CDNA Position: Q1 2022 in Review
Quantamental Technologies sold out of CareDx (CDNA) in Q1 2022, closing a stake of 6,137 shares — an estimated $279K sold.
Quantamental Technologies first reported a position in CDNA in Q2 2019 and held it in 3 quarters. The position peaked at $279K in Q4 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Quantamental Technologies reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Quantamental Technologies sold 6,137 CareDx shares in Q1 2022, an estimated $279K.
- Quantamental Technologies first reported a position in CareDx in Q2 2019 and held it in 3 quarters.
- Quantamental Technologies's CareDx position peaked at $279K in Q4 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Quantamental Technologies's 13F filing for Q1 2022, filed 16 May 2022.